Bruker's Q4 Revenues Drop 9 Percent; Shares Rise as It Beats Estimates | GenomeWeb

NEW YORK (GenomeWeb News) – Bruker today reported that its fourth-quarter revenues fell 9 percent and its profit declined 35 percent. But its shares rose in early Tuesday trade as the firm beat analysts' consesus estimates for revenue and earnings per share.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.